InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Files Quarterly Report Highlighting Broad-Spectrum Antiviral Candidate NV-387
NanoViricides, Inc. (NYSE American: NNVC) filed its Form 10-Q for the quarter ended Sept. 30, 2025, and detailed progress on NV-387, a first-in-class broad-spectrum antiviral designed to resist viral escape by mimicking conserved sulfated proteoglycan receptors used by more than 90% of viruses. The Company noted that NV-387’s mechanism may address major unmet needs across multiple viral diseases, including Influenza strains prone to rapid resistance,…